Capital Clinical Research Associates, LLC   Report issue

For profit Phase 4
Founded: Rockville MD United States (2002)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2011
NCT01556971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

rimabotulinumtoxinB (Myobloc) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2